Clinical Breast Cancer : Impact Factor & More
eISSN: 1938-0666pISSN: 1526-8209
Share this on:
Key Metrics
CiteScore 
5.9
H-Index
74
Impact Factor
< 5
SJR
Q2Oncology
SNIP
1.13
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Clinical Breast Cancer
Clinical Breast Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | CIG MEDIA GROUP, LP |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Clinical Breast Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Clinical Breast Cancer
Comment on Clinical Outcomes in Early-Stage Metaplastic Breast Cancer.
- 1 Dec 2025
- Clinical breast cancer
Research progress of radiotherapy combined with immunotherapy for breast cancer: mechanism exploration and clinical translation
- 1 Dec 2025
- Clinical Breast Cancer
Comment on "Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study".
- 1 Dec 2025
- Clinical breast cancer
Editorial for "Real World Safety of Adjuvant Ultra Hypofractionated Radiotherapy in Nonmetastatic Breast Cancer: Acute Cutaneous Toxicity and Aesthetic Outcomes".
- 1 Dec 2025
- Clinical breast cancer
Letter to the Editor Regarding the Article "Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients with HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study".
- 1 Dec 2025
- Clinical breast cancer
Comment on "Clinical and Pathological Features of Early-Stage Metaplastic Carcinoma and Associated Patient Outcomes".
- 1 Dec 2025
- Clinical breast cancer
Comment on Clinical Outcomes in Early-Stage Metaplastic Breast Cancer.
- 1 Dec 2025
- Clinical breast cancer
Research progress of radiotherapy combined with immunotherapy for breast cancer: mechanism exploration and clinical translation
- 1 Dec 2025
- Clinical Breast Cancer
Comment on "Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study".
- 1 Dec 2025
- Clinical breast cancer
Editorial for "Real World Safety of Adjuvant Ultra Hypofractionated Radiotherapy in Nonmetastatic Breast Cancer: Acute Cutaneous Toxicity and Aesthetic Outcomes".
- 1 Dec 2025
- Clinical breast cancer
Letter to the Editor Regarding the Article "Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients with HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study".
- 1 Dec 2025
- Clinical breast cancer
Comment on "Clinical and Pathological Features of Early-Stage Metaplastic Carcinoma and Associated Patient Outcomes".
- 1 Dec 2025
- Clinical breast cancer
FAQs on Clinical Breast Cancer
How long has Clinical Breast Cancer been actively publishing? 
What is the publishing frequency of Clinical Breast Cancer?
How many articles did Clinical Breast Cancer publish last year?
What is the eISSN & pISSN for Clinical Breast Cancer?
What is Citescore for Clinical Breast Cancer?
What is the H Index for Clinical Breast Cancer ?
What is SNIP score for Clinical Breast Cancer?
What is the SJR for Clinical Breast Cancer?
Who is the publisher of Clinical Breast Cancer?
